In the case of ZNF154, we identified a subgroup of HNSCC patients (n = 127, 25% of cohort) where ZNF154 expression in their primary tumour was not silenced, and was comparable to that observed in non-tumor adjacent tissue. The gene discussed is ZNF154; the disease is neoplasm.